Comparison of Paricalcitol With Maxacalcitol Injection in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism

Publisher： John Wiley & Sons Inc

E-ISSN： 1744-9987|19|3|225-234

ISSN： 1744-9979

Source： THERAPEUTIC APHERESIS AND DIALYSIS, Vol.19, Iss.3, 2015-06, pp. : 225-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Effectiveness of Paricalcitol versus Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c151-c159

Karger

Access to resources Recommend Favorite

Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients

By Sharma Amit   Ketteler Markus   Marshall Thomas S.   Khan Samina S.   Schumock Glen T.  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1129-1136

Informa Healthcare

Access to resources Recommend Favorite

Paricalcitol Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients: A German-Austrian, Single-Arm, Open-Label, Prospective, Noninterventional, Observational Study

By  

Nephron Clin Pract, Vol. 126, Iss. 1, 2014-01 ,pp. : 39-50

Karger

Access to resources Recommend Favorite

Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1280-1285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1280-1285

John Wiley & Sons Inc

Access to resources Recommend Favorite